Meet George Chang, M.D.
George J. Chang, MD, MS, MHCM, FACS, FASCRS, FSSO
Department of Colon & Rectal Surgery, Division of Surgery
Present Title & Affiliation
Primary Appointment
Associate Vice President, Clinical Growth and Site Integration, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Endowed Distinguished Chair Sue and Radcliff Killam Chair, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor (Joint appointment), Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Cancer treatment outcomes research. Clinical epidemiology of cancer treatment outcomes. Decision modeling for cancer treatment.
Clinical trials in cancer therapy.
Education & Training
Degree-Granting Education
| 2023 | Harvard T.H. Chan, School of Public Health, Boston, Massachusetts, US, MHCM in Master of Health Care Management |
| 2007 | The University of Texas Health Science Center at Houston Medical School, Houston, Texas, US, M.S. in Master of Science in Clinical Research |
| 1995 | University of California, Los Angeles, California, US, MD |
| 1991 | University of California, Berkeley, California, US, BA in Biochemistry |
Postgraduate Training
| 2024-2024 | The Leading Teams Core Cohort, The University of Texas MD Anderson Cancer Center Leadership Institute, Houston, Texas |
| 2022-2022 | Emotional Intelligence Certificate, Vanderbilt University |
| 2020-2020 | Rice Advanced Management Program, Rice University School of Business, Houston, Texas |
| 2015-2015 | MD Anderson Faculty Leadership Academy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas |
| 2013-2013 | Leadership Development for Physicians in Academic Health Centers, Harvard School of Public Health, Boston, Massachusetts |
| 2009-2009 | Measurement, Design, and Analysis Methods for Health Outcomes Research, Harvard School of Public Health, Boston, Massachusetts |
| 2003-2004 | Clinical Fellow, Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota |
| 2002-2003 | Chief Resident, Surgery, University of California, San Francisco, California |
| 1998-2001 | Post-doctoral Research Fellow, Surgery, University of California, San Francisco, California |
| 1996-2002 | Resident, Surgery, University of California, San Francisco, California |
| 1995-1996 | Intern, Surgery, University of California, San Francisco, California |
Licenses & Certifications
| 2024 | Fellow of the American Society of Clinical Oncology |
| 2008 | Fellow of the American Society of Colon and Rectal Surgeons |
| 2008 | Fellow of the Society of Surgical Oncology |
| 2007 | Fellow of the American College of Surgeons |
| 2005 | American Board of Colon and Rectal Surgery |
| 2004 | American Board of Surgery |
Experience & Service
Faculty Academic Appointments
John E. and Dorothy J. Harris Professorship in Gastrointestinal Cancer Research, Department of Surgical Oncology - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020
Associate Professor, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2015
Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2010
Administrative Appointments/Responsibilities
Department Chair ad interim, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2025
Associate Vice President, Regional Surgery Strategy, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2025
Deputy Department Chair, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2020
Activity Director, The Multidiscplianry Rectal Cancer Conference, Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2022
Director, Advanced Colon and Rectal Surgical Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020
Chief, Section of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020
Director of Clinical Operations, Department of Minimally Invasive and New Technologies in Oncologic Surgery Program, The University of Texas MD Anderson Cancer Center, Houston, 2011 - 2019
Associate Medical Director, Colorectal Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2017
Other Professional Positions
Advisory Board, Tempus, Chicago, IL, 2024
Advisory Board, Agency for Healthcare Research and Quality, Rockville, MD, 2023 - 2024
Advisory Board, Iota Biosciences, Alameda, CA, 2023 - 2024
Panel, Ethicon Endo-Surgery, Inc, Cincinnati, OH, 2020
Scientific Advisor, 11/Health, Irvine, CA, 2020
Consultant, MORE Health, United States, 2018 - 2019
Consultant, Ethicon Biosurgery Sentinel GI Advisory Board, Somerville, NJ, 2014 - 2015
Consultant, Ethicon Endo-Surgery, Inc, Cincinnati, OH, 2013 - 2015
Advisory Board, Synovis, St. Paul, MN, 2012
Ad hoc advisory, Genomic Health, Redwood City, CA, 2011
Ad hoc, Intuitive Surgical, Sunnyvale, CA, 2010 - 2011
Ad hoc advisory, Agendia, Huntington Beach, CA, 2010
Ad hoc advisory, Genzyme, Cambridge, MA, 2008 - 2009
Ad hoc consultant, Covidien, Norwalk, CT, 2008 - 2009
Consultantships, The University of Texas MD Anderson Orlando Teleconference GI Surgical Oncology, Houston, 2007 - 2010
Ad hoc Consultant, Lifecell Corporation, Branchburg, NJ, 2007
Extramural Institutional Committee Activities
Member, MD Anderson Physicians Network Board of Directors, The University of Texas MD Anderson Cancer Center, 2024 - Present
Chair, Editor in Chief Search Committee, Diseases of the Colon and Rectum, 2024 - 2026
Search Committee, Chief Nursing Executive, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, National Comprehensive Cancer Network Colon | Rectal | Anal Cancers Panel, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Internal Advisory Board for the Shared Decision Making Core, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Division of Surgery Executive Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, COVID-19 Core Leadership Team, Colorectal Service Line Lead, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Member, Cancer Survivorship Steering Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2018 - 2022
Member, Search Committee, Department of Melanoma Chair, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Cancer Survivorship Research Advisory Workgroup, The University of Texas MD Anderson Cancer Center, 2017 - 2020
Member, Vice Provost Population Science Advisory Council, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Institutional Staging Workgroup, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Clinical Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Search Committee, Department of Gastrointestinal Medical Oncology Chair, The University of Texas MD Anderson Cancer Center, 2014 - Present
Surgical Oncology Representative, Division of Surgery Cancer Network Operations Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2022
Member, Clinical Research Protocol Review Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, eResearch Executive Steering Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Surgical Oncology Clinical Research Oversight Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2016
Member, Perioperative Enterprise Laparoscopic Instrumentation Upgrade Task Force, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Surgical Oncology Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2020
Member, Perioperative Enterprise Endoscopic Instrumentation Upgrade Taskforce, The University of Texas MD Anderson Cancer Center, 2009 - 2011
Member, Clinical Affairs Sub Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2009 - 2014
Member, Volume Outcomes in Cancer Surgery Workgroup, The University of Texas MD Anderson Cancer Center, 2009 - 2011
Member, Colon and Rectal Cancer Treatment Guidelines Development Core Committee, The University of Texas MD Anderson Cancer Center, 2008 - Present
Member, Perioperative Enterprise HD Video Upgrade Taskforce, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2007 - 2019
Alternate Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2007 - 2008
Member, Commission on Cancer Site Visit Preparation Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2011
ex officio, Medical Records Subcommittee, The University of Texas MD Anderson Cancer Center, 2006 - 2014
Executive Committee Member, Minimally Invasive and New Technologies in Oncology Surgery (MINTOS), The University of Texas MD Anderson Cancer Center, 2006 - Present
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2005 - 2008
Member, 100K Lives Charter Team, The University of Texas MD Anderson Cancer Center, 2005 - Present
Member, Cancer Liaison Physician, The University of Texas MD Anderson Cancer Center, 2005 - Present
Member, Multidisciplinary Colorectal Cancer Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2004 - Present
Editorial Activities
Editorial Board, Journal of Clinical Oncology, 2026 - 2028
Member, Editorial Advisory Board, CANCER, 2026 - 2028
Editor, Annals of Gastroenterological Surgery, 2020 - Present
Member of Editorial Review Board, British Journal of Surgery, 2019 - 2024
Member of Editorial Review Board, Annals of Gastroenterological Surgery, 2018 - Present
Section Editor, Colorectal Oncology, Society of Surgical Oncology, 2015 - Present
Member of Editorial Review Board, Frontiers in Oncology, 2014 - 2018
Member of Editorial Review Board, Journal of Clinical Oncology, 2012 - 2019
Associate Editor, Diseases of the Colon & Rectum, 2010 - Present
Member of Editorial Review Board, Annals of Surgical Oncology, 2009 - Present
Honors & Awards
| 2025 - Present | America's Leading Doctors, Newsweek |
| 2023 | CAHPS top 1% performer, Physician Referral Service Annual Business Meeting and Recognition Awards |
| 2023 | 2020 High Impact Article of Annals of Laparoscopic and Endoscopic Surgery, Annals of Laparoscopic and Endoscopic Surgery |
| 2021 | 2021 National Top 10% Providers, Press Gainey |
| 2020 | 2020 National Top 1% Providers, Press Gainey |
| 2019 | 2019 Star Performance, Diseases of the Colon and Rectum |
| 2019 | Outstanding Teaching Award for Research, Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center |
| 2019 | SSO 2019 Best Clinical Research Paper (to mentee Zafar), Society of Surgical Oncology |
| 2018 | National Top 1% Providers, Press Gainey |
| 2015 | MD Anderson Cancer Center Presidential Clinical Technology Award for Faculty Excellence |
| 2014 | Most Outstanding Abstract Award, Academic Surgical Congress Annual Meeting |
| 2014 | Outstanding Teacher of the Year in Research Award, Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center |
| 2014 | Trainee Excellence Award (to mentee Christina Bailey), MD Anderson Alumni & Faculty Association |
| 2011 | Award for Outstanding Paper at the 2011 ASCRS Annual Meeting, Michigan Society of Colon and Rectal Surgeons |
| 2011 | Best Clinical Abstract Award, American Society of Colon and Rectal Surgeons |
| 2011 | Certificate of Merit, Radiological Society of North America |
| 2010 - 2023 | America's Top Surgeons, Consumers Research Council of America |
| 2010 | Trainee Research Poster Competition Finalist-to Mentee Tawnya Bowles, MD, UT MD Anderson Cancer Center |
| 2008 - 2011 | American Society of Clinical Oncology Career Development Award |
| 2007 | Outstanding Abstract Award (to mentee Choi), ASCO GI Cancers Symposium |
| 2007 - 2023 | Best Doctors in America |
| 2007 | Outstanding Manuscript Award (to mentee Lim), Society of Surgical Oncology |
| 2006 | Department of Surgical Oncology Outstanding Teacher of the Year, UT M. D. Anderson Cancer Center |
| 2006 | Sharon K. Martin Award for Performance Improvement Excellence (Surgical Instrument Reduction) |
| 2003 | Department of Surgery Azakie-Chessen Award for Compassion, University of California San Francisco School of Medicine |
| 2001 | Maurice Galante Award for Most Outstanding Resident Research, University of California San Francisco School of Medicine |
| 1999 - 2001 | A.P. Giannini Foundation Research Fellowship Award, Bank of America |
| 1999 | British Journal of Surgery Outstanding Resident Award |
| 1998 | Alpha Omega Alpha Distinguished Resident Teaching Award, University of California San Francisco School of Medicine |
| 1995 | Alpha Omega Alpha Delta Chapter, University of California Los Angeles School of Medicine |
| 1995 | William N. Valentine Medical Student Award for Highest Performance in Medicine |
| 1992 - 1993 | Josiah S. Brown Award for Excellence in Research, University of California Los Angeles School of Medicine |
| 1991 - 1995 | UCLA Medical Student Honors Thesis and Dean's Award |
| 1991 | Departmental Honors, University of California Berkeley Department of Biochemistry |
| 1990 | Phi Beta Kappa |
| 1987 - 1991 | Dean Honor Roll, UC Berkeley College of Letters and Sciences |
| 1987 - 1991 | Golden Key National Honor Society, University of California Berkeley |
| 1987 - 1991 | Honors Research Thesis, UC Berkeley Department of Biochemistry |
| 1987 - 1991 | National Merit Scholar, University of California Berkeley |
| 1985 | Summer Student Research Fellowship, California Academy of Science/City of Hope Beckman Research Institute |
Professional Memberships
Grant & Contract Support
| Date: | 2024 - 2029 |
| Title: | An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients |
| Funding Source: | University of California |
| Role: | Co-PI |
| ID: | 1R01CA284748-01A1 |
| Date: | 2022 - 2024 |
| Title: | PrehabPal: A digital tool to help frail elders prepare for cancer surgery |
| Funding Source: | Univ of California San Francisco |
| Role: | PI |
| ID: | FP00016259 |
| Date: | 2021 - 2024 |
| Title: | Magnetic nanoparticles for Precision Surgical Oncology and Radiotherapy |
| Funding Source: | Ferronova Pty Ltd |
| Role: | PI |
| Date: | 2021 - 2022 |
| Title: | Enhancing Recovery Beyond Discharge (Enhanced Recovery Plus) |
| Funding Source: | American Soc of Colon and Rectal Surgeon |
| Role: | PI |
| Date: | 2021 - 2026 |
| Title: | Effectiveness-Implementation trial of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer patients |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2019 - 2023 |
| Title: | Older Mens Decision Making about Active Surveillance for Prostate Cancer |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-Mentor |
| ID: | MRSG-18-225-01-CPPB |
| Date: | 2019 - 2025 |
| Title: | NIH/NCI/Mayo. Alliance NCORP Research Base |
| Funding Source: | Mayo Clinic Rochester |
| Role: | PI |
| ID: | 2UG1CA189823-06 |
| Date: | 2019 - 2025 |
| Title: | UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1 |
| Funding Source: | UT MD Anderson Cancer Center Network Lead Academic Participating Site |
| Role: | Co-PI |
| ID: | 5UG1CA233329-02 |
| Date: | 2018 - 2025 |
| Title: | Alliance NCORP Research Base - Cancer Care Delivery Research - OPTI-Surg Study |
| Funding Source: | Mayo Clinic Rochester |
| Role: | PI |
| ID: | 5UG1CA1898823-05R |
| Date: | 2018 - 2023 |
| Title: | Multicenter Cluster Randomized Trail of Preoperative Frailty Assessment and Intervention for Patients Undergoing Major Surgery |
| Funding Source: | Alliance NCORP Research Base |
| Role: | PI |
| Date: | 2018 - Present |
| Title: | Alliance NCORP Research Base – Cancer Care Delivery Research – OPTI-Surg Study |
| Funding Source: | NIH/NCI/Mayo |
| Role: | PI |
| ID: | 2UG1CA1898823-06 |
| Date: | 2018 - 2020 |
| Title: | Organ Preservation with Active Surveillance after Chemoradiation in Rectal Cancer (OPTION), a Prospective trial |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Principal Investigator-MDACC |
| Date: | 2016 - 2018 |
| Title: | Enhanced Accelerated Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI), a Randomized Trial |
| Funding Source: | American Society of Colon and Rectal Surgeons |
| Role: | PI |
| Date: | 2016 - 2021 |
| Title: | Large Pragmatic Trial. Patient Centered Outcomes Research Institute |
| Funding Source: | Comparison of Operative to Medical Endocrine Therapy (COMET) for low risk DCIS |
| Role: | Co-I |
| Date: | 2016 - 2021 |
| Title: | Arizona State University Exercise Intervention for Rectal Cancer Survivors |
| Funding Source: | NIH |
| Role: | Co-I |
| Date: | 2015 - 2019 |
| Title: | Optimizing the Effectiveness of Routine Post-Treatment Surveillance in Prostate Cancer Survivors |
| Funding Source: | Alliance for Clinical Trials in Oncology Foundation through Patient Centered Outcomes Research Institute - PCORI |
| Role: | Principal Investigator-MDACC |
| Date: | 2014 - 2017 |
| Title: | Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer |
| Funding Source: | ALLIANCE for Clinical Trials in Oncology Foundation through Patient Centered Outcomes Research Institute - PCORI |
| Role: | PI |
| Date: | 2014 - 2020 |
| Title: | UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Principal Investigator-MDACC |
| ID: | 5U10CA180858 |
| Date: | 2014 - 2020 |
| Title: | Chang NCTN-LAP |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2014 - 2017 |
| Title: | Improving the Effectiveness of Routine Surveillance Following Lung Cancer Resection |
| Funding Source: | ALLIANCE for Clinical Trials in Oncology Foundation through Patient Centered Outcomes Research Institute - PCORI |
| Role: | Principal Investigator-MDACC |
| Date: | 2014 - 2019 |
| Title: | Alliance NCORP Reserach Base |
| Funding Source: | NCORP |
| Role: | Co-I |
| ID: | 5UG1CA189823-04 |
| Date: | 2014 - 2017 |
| Title: | CCARE Colon Cancer Adjuvant Research and Experience. A Critical Decision Support Tool for Stage II Colon Cancer Patients and their Physicians |
| Funding Source: | Arizona State University through Patient Centered Outcomes Research Institute - PCORI |
| Role: | Principal Investigator-MDACC |
| Date: | 2013 - 2014 |
| Title: | American College of Surgeons Oncology Group/ NCI Community Clinical Oncology Program (CCOP) Research Base |
| Funding Source: | ACOSOG |
| Role: | Co-I |
| ID: | 5U10CA149950-03 |
| Date: | 2013 - 2015 |
| Title: | AMPK directs the balance between mutant Kras and PI3K signaling and defines molecular subsets in colorectal cancer |
| Funding Source: | MD Anderson Cancer Center Sister Institution Network Fund |
| Role: | Co-I |
| Date: | 2012 - 2022 |
| Title: | A Phase II/III Trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision |
| Funding Source: | ALLIANCE 7U10CA076001 |
| Role: | PI |
| ID: | NCCTG N1048 |
| Date: | 2012 - 2014 |
| Title: | A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Gastrointestinal Anastomosis Techniques |
| Funding Source: | Ethicon |
| Role: | PI |
| ID: | 2012-0235 |
| Date: | 2011 - 2021 |
| Title: | A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients using ColoPrint |
| Funding Source: | Agendia |
| Role: | PI |
| ID: | CS2011-00035445LGA-01 |
| Date: | 2011 - 2016 |
| Title: | Alliance for Clinical Trials in Oncology Network Foundation |
| Funding Source: | ACTION Alliance /Brigham and Women's Hospital |
| Role: | Committee Co-Chair |
| Date: | 2011 - 2014 |
| Title: | A phase III prospective randomized trial comparing laparoscopic-assisted resection versus open resection for rectal cancer |
| Funding Source: | American College of Surgeons Oncology Group/NCI |
| Role: | PI |
| ID: | 7U10CA076001-16 ACOSOG-Z6051 |
| Date: | 2010 - 2013 |
| Title: | Statin Polyp Prevention Trial in Patients with Resected Colon Cancer (Phase III) |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | NSABP P-5 |
| Date: | 2009 - 2014 |
| Title: | Optimizing Treatment of Rectal Cancer Using a Markov Decision Model |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 5 K07 CA133187-05 |
| Date: | 2008 - 2011 |
| Title: | Development of a Markov Model for Optimized Treatment of Rectal Cancer |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| ID: | Career Development Award |
| Date: | 2007 - Present |
| Title: | Leveraging Existing Data for Decision Support |
| Funding Source: | University of Texas Health Sciences Center, Center for Clinical and Translational Sciences Pilot Grant |
| Role: | Co-PI |
| Date: | 2007 - Present |
| Title: | Development of a Markov Decision Model to Optimize Rectal Cancer Therapy |
| Funding Source: | American Cancer Society Career Development Award |
| Role: | PI |
| Date: | 2006 - Present |
| Title: | Lymph Recovery as a Quality Indicator in Colon Cancer Surgery |
| Funding Source: | American Society of Colon and Rectal Surgery Research Foundation |
| Role: | PI |
| Date: | 1999 - 2001 |
| Title: | Generation of Tolerance to Alloantigen in a Transplant Model Using Dendritic Cells, Costimulation Blockade and Immunomodulation |
| Funding Source: | Bank of America, A.P. Giannini Foundation |
| Role: | Research Fellow |
| Date: | 1998 - 1999 |
| Title: | Generation of Tolerance to Alloantigen in a Transplant Model Using Dendritic Cells, Costimulation Blockade and Immunomodulation |
| Funding Source: | National Kidney Foundation |
| Role: | Research Fellow |
| Date: | 1993 |
| Title: | Oxidation of Low-Density Lipoprotein by Nitric Oxide |
| Funding Source: | UCLA School of Medicine STTP Research Grant |
| Role: | Student Investigator |
| Date: | 1992 |
| Title: | Oxidation of Low-Density Lipoprotein by nitric oxide |
| Funding Source: | UCLA School of Medicine STTP Research Grant |
| Role: | Student Investigator |
| Title: | AYA ACCESS Study: An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients |
| Funding Source: | NIH/R01 |
| Role: | Co-I |
| Title: | General Surgery Resident Research Initiation Grant |
| Funding Source: | American Society of Colon & Rectal Surgeons |
| Role: | Co-Mentor |
| Title: | Human Centered Design for a Survivorship Social Network for Rectal Cancer |
| Funding Source: | UT Austin/MD Anderson Cancer Center |
| Role: | Co-PI |
| Title: | Exercise Intervention for Rectal Cancer Survivors |
| Funding Source: | University of Pennsylvania/NIH |
| Role: | Site PI |
| ID: | R01 CA226252-01 |
Selected Publications
Peer-Reviewed Articles
- White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. Ann Surg 278(4):538-548, 2023. e-Pub 2023. PMID: 37465976.
- Manisundaram N, DiBrito SR, Hu CY, Kim Y, Wick E, Palis B, Peacock O, Chang GJ. Reporting of Circumferential Resection Margin in Rectal Cancer Surgery. JAMA Surg 158(11):1195-1202, 2023. e-Pub 2023. PMID: 37728906.
- Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L, Gollub M, Rogak L, Ginos B, Mazza GL, Colgrove B, Chang G, Minasian L, Denicoff A, Thanarajasingam G, Musher B, George T, Venook A, Farma J, O'Reilly E, Meyerhardt JA, Shi Q, Schrag D. Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048). J Clin Oncol 41(21):JCO2300903, 2023. e-Pub 2023. PMID: 37270691.
- Peacock O, Manisundaram N, Kim Y, Konishi T, Stanietzky N, Vikram R, Bednarski BK, You YN, Chang GJ. Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything. Br J Surg 110(8):985-986, 2023. e-Pub 2023. PMID: 37150892.
- Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, Goldberg J, Al Baghdadi T, Goodman KA, McWilliams RR, Farma JM, George TJ, Kennecke HF, Shergill A, Montemurro M, Nelson GD, Colgrove B, Gordon V, Venook AP, O'Reilly EM, Meyerhardt JA, Dueck AC, Basch E, Chang GJ, Mamon HJ. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med 389(4):322-334, 2023. e-Pub 2023. PMID: 37272534.
- Leitao MM, Kreaden US, Laudone V, Park BJ, Pappou EP, Davis JW, Rice DC, Chang GJ, Rossi EC, Hebert AE, Slee A, Gonen M. The RECOURSE Study: Long-term Oncologic Outcomes Associated with Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, cOlorectal, lUng, or pRoState cancEr: a Systematic Review and meta-analysis. Ann Surg 277(3):387-396, 2022. e-Pub 2022. PMID: 36073772.
- Schumacher JR, Neuman HB, Yu M, Vanness DJ, Si Y, Burnside ES, Ruddy KJ, Partridge AH, Schrag D, Edge SB, Zhang Y, Jacobs EA, Havlena J, Francescatti AB, Winchester DP, McKellar DP, Spears PA, Kozower BD, Chang GJ, Greenberg CC, Working Group AACBCS. Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01). J Natl Cancer Inst 114(10):1371-1379, 2022. e-Pub 2022. PMID: 35913454.
- Peacock O, Vilar E, Trueba MG, Thirumurthi S, Chang GJ, You YN. Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines. Gastroenterology, 2022. e-Pub 2022. PMID: 35987446.
- Snyder RA, Hu CY, DiBrito SR, Chang GJ. Association of Medicaid expansion with racial disparities in cancer stage at presentation. Cancer 128(18):3340-3351, 2022. e-Pub 2022. PMID: 35818763.
- Peacock O, Manisundaram N, Dibrito SR, Kim Y, Hu CY, Bednarski BK, Konishi T, Stanietzky N, Vikram R, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer after Total Neoadjuvant Therapy (TNT). Ann Surg 276(4):654-664, 2022. e-Pub 2022. PMID: 35837891.
- De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
- Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg 109(6):489-492, 2022. e-Pub 2022. PMID: 35576377.
- Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg, 2022. e-Pub 2022. PMID: 35373260.
- Tilburt JC, Zahrieh D, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb RL, Chang GJ, Morris MJ, Kovac EZ, Babaian KN, Sloan JA, Basch EM, Peil ES, Dueck AC, Novotny PJ, Paskett ED, Buckner JC, Joyce DD, Montori VM, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). Cancer 128(6):1242-1251, 2021. e-Pub 2021. PMID: 34890060.
- Ludford K, Cohen R, Svrcek M, Foo WC, Colle R, Parc Y, Thomas JV, Morris VK, Kopetz S, Chang GJ, Overman M, Andre T. Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer. J Natl Cancer Inst 113(2):208-211, 2021. e-Pub 2021. PMID: 32294214.
- Kothari AN, Trans AT, Caudle AS, Clemens MW, Katz MHG, Woodman SE, Chang GJ. Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges. Br J Surg 108(1):e24-e26, 2021. e-Pub 2021. PMID: 33640925.
- Healy MA, Peacock O, Hu CY, Bednarski BK, Tillman MM, Messick C, Kaur H, Chang GJ. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action. Ann Surg, 2020. e-Pub 2020. PMID: 33630474.
- Snyder RA, Hu CY, Zafar SN, Francescatti A, Chang GJ. Racial Disparities in Recurrence and Overall Survival in Patients with Locoregional Colorectal Cancer. J Natl Cancer Inst 113(6):770-777, 2020. e-Pub 2020. PMID: 33231683.
- An Y, Bellato V, Konishi T, Pellino G, Sensi B, Siragusa L, Franceschilli M, Sica GS, Group SC. Surgeons' fear of getting infected by COVID19: A global survey. Br J Surg 107(11):e543-e544, 2020. e-Pub 2020. PMID: 32808678.
- Collaborative P. The global cost of pelvic exenteration: in-hospital perioperative costs. Br J Surg 107(11):e470-e471, 2020. e-Pub 2020. PMID: 33460051.
- Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Tillman MM, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes. Br J Surg 107(12):1552-1557, 2020. e-Pub 2020. PMID: 32996597.
- Collaborative P. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer. Br J Surg 107(11):e547-e548, 2020. e-Pub 2020. PMID: 32779191.
- Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS, Group SC. Impact of asymptomatic COVID-19 patients in global surgical practice during the COVID-19 pandemic. Br J Surg 107(10):e364-e365, 2020. e-Pub 2020. PMID: 32767367.
- Chang GJ, You YNY, Russell CA, Tierno MB, Turner M, Bennett JP, Lau A, Hochster HS. Young-Onset Colon Cancer and Recurrence Risk By Gene Expression. J Natl Cancer Inst 112(11):1170-1173, 2020. e-Pub 2020. PMID: 32040172.
- Massarweh NN, Chang GJ. Translating Research Findings Into Practice-The Unfulfilled and Unclear Mission of Observational Data. JAMA Surg 154(2):103-104, 2019. e-Pub 2019. PMID: 30422255.
- Bednarski BK, Nickerson TP, You YN, Messick CA, Speer B, Gottumukkala V, Manandhar M, Weldon M, Dean EM, Qiao W, Wang X, Chang GJ. Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial). Br J Surg 106(10):1311-1318, 2019. e-Pub 2019. PMID: 31216065.
- Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N, Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, Weiser MR, Kolevska T, Reeve BB, Bruner DW, Schrag D. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol 36(31):JCO2018788620, 2018. e-Pub 2018. PMID: 30204536.
- McMurry TL, Stukenborg GJ, Kessler LG, Colditz GA, Wong ML, Francescatti AB, Jones DR, Schumacher JR, Greenberg CC, Chang GJ, Winchester DP, McKellar DP, Kozower BD. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study. Ann Surg 268(4):632-639, 2018. e-Pub 2018. PMID: 30004919.
- Kolarich A, George TJ, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer 124(17):3510-3519, 2018. e-Pub 2018. PMID: 29984547.
- Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Working Group AFCTIONCSO. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA 319(20):2104-2115, 2018. e-Pub 2018. PMID: 29800181.
- Delitto D, George TJ, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst 110(5):460-466, 2018. e-Pub 2018. PMID: 29165692.
- Mason MC, Chang GJ, Petersen LA, Sada YH, Tran Cao HS, Chai C, Berger DH, Massarweh NN. National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up?. Ann Surg 266(6):1013-1020, 2017. e-Pub 2017. PMID: 27617852.
- Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, Weaver KE. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. J Am Coll Radiol 14(12):1530-1537, 2017. e-Pub 2017. PMID: 29055605.
- Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth 119(4):750-764, 2017. e-Pub 2017. PMID: 29121285.
- Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):JCO2016721464, 2017. e-Pub 2017. PMID: 28657814.
- Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123(7):1124-1133, 2017. e-Pub 2017. PMID: 27479827.
- Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractioned Accelerated Reirradiation for Rectal Cancer. An Analysis of Outcomes and Toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
- de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol 34(25):3039-3046, 2016. e-Pub 2016. PMID: 27432916.
- Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc 84(1):115-125.e4, 2016. e-Pub 2016. PMID: 26769407.
- You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg 103(6):753-762, 2016. e-Pub 2016. PMID: 26933792.
- Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Cancer (OSTRiCh) CFOTTOR. High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. Ann Surg 262(6):891-8, 2015. e-Pub 2015. PMID: 26473651.
- Patel S, Chang GJ. Primary Tumor Resection in Metastatic Colorectal Cancer: Please Pass the Salt. JAMA Oncol 1(9):1213-4, 2015. e-Pub 2015. PMID: 26378904.
- Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Maun D, Chang GJ, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA 314(13):1346-55, 2015. e-Pub 2015. PMID: 26441179.
- Massarweh NN, Haynes AB, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?. Ann Surg 262(2):312-20, 2015. e-Pub 2015. PMID: 25185467.
- Hu CY, Bailey CE, Chang GJ. Less Surgery, Improved Survival From Stage IV Colorectal Cancer?-Reply. JAMA Surg 150(8):819-20, 2015. e-Pub 2015. PMID: 26107989.
- Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 112(6):1088-97, 2015. e-Pub 2015. PMID: 25688736.
- Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative Effectiveness of Laparoscopy vs. Open Colectomy Among Non-metastatic Colon Cancer Patients: An Analysis Using the National Cancer Data Base. J Natl Cancer Inst 107(3), 2015. e-Pub 2015. PMID: 25663688.
- Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time Trend Analysis of Primary Tumor Resection for Stage IV Colorectal Cancer: Less Surgery, Improved Survival. JAMA Surg 150(3):245-51, 2015. e-Pub 2015. PMID: 25588105.
- Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surg 150(1):1-6, 2015. e-Pub 2015. PMID: 25372703.
- Kneuertz PJ, GJ C, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains. JAMA Surg 150(5):402-9, 2015. e-Pub 2015. PMID: 25806815.
- Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw 13(7):865-72, 2015. e-Pub 2015. PMID: 26150580.
- Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer 120(8):1162-70, 2014. e-Pub 2014. PMID: 24474245.
- Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN. Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer. J Clin Oncol 32(9):942-8, 2014. e-Pub 2014. PMID: 24516014.
- Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2014. PMID: 24315563.
- Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, Chang GJ, Dietz DW, Cancer (OSTRiCh) CFOTTOR. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg 260(4):625-31; discussion 631-2, 2014. e-Pub 2014. PMID: 25203879.
- Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 32(27):2967-74, 2014. e-Pub 2014. PMID: 25092785.
- Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013. e-Pub 2013. PMID: 24037775.
- Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A Novel Risk-Adjusted Nomogram for Rectal Cancer Surgery Outcomes. JAMA Surg 148(8):1-9, 2013. e-Pub 2013. PMID: 23803722.
- Collaborative BT. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):E1-E33, 2013. e-Pub 2013. PMID: 23754654.
- Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM Staging for Adenocarcinomas of the Appendix: The Prognostic Impact of Histological Grade. Ann Surg 257(6):1072-8, 2013. e-Pub 2013. PMID: 23001080.
- Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer 119(10):1900-7, 2013. e-Pub 2013. PMID: 23408226.
- Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer 108(7):1508-14, 2013. e-Pub 2013. PMID: 23470470.
- Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 119(8):1593-601, 2013. e-Pub 2013. PMID: 23280510.
- Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-41, 2013. e-Pub 2013. PMID: 24089344.
- Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 30(15):1770-6, 2012. e-Pub 2012. PMID: 22493423.
- Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN. Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer. J Clin Oncol 30(9):972-9, 2012. e-Pub 2012. PMID: 22355049.
- Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 77(1):60-5, 2010. e-Pub 2010. PMID: 19695792.
- Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76(3):824-30, 2010. e-Pub 2010. PMID: 19464823.
- Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-4, 2010. e-Pub 2010. PMID: 19864936.
- Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102(6):401-9, 2010. e-Pub 2010. PMID: 20185801.
- Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 27(35):5938-43, 2009. e-Pub 2009. PMID: 19805670.
- Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy. J Clin Oncol 27(22):3677-83, 2009. e-Pub 2009. PMID: 19470929.
- Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys 74(3):818-23, 2009. e-Pub 2009. PMID: 19147305.
- Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26(32):5254-60, 2008. e-Pub 2008. PMID: 18854565.
Review Articles
- Shen C, Tannenbaum D, Horn R, Rogers J, Eng C, Zhou S, Johnson B, Kopetz S, Morris V, Overman M, Parseghian C, Chang GJ, Lopez-Olivo MA, Kanwal R, Ellis LM, Dasari A. Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review. JAMA Netw Open 5(5):e2213588, 2022. e-Pub 2022. PMID: 35608860.
- Bhutiani N, Peacock O, Chang GJ. A practical framework for the targeted use of total neoadjuvant therapy for rectal cancer. Cancer 128(11):2064-2072, 2022. e-Pub 2022. PMID: 35377951.
- Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pre-Existing Melanoma and Hematological Malignancies, Prognosis and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement. Am J Transplant 21(2):475-483, 2020. e-Pub 2020. PMID: 32976703.
- Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qauod T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pre-Transplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement. Am J Transplant 21(2):460-474, 2020. e-Pub 2020. PMID: 32969590.
Professional Educational Materials
- Benson AB, Venook AP, Adam M, Chang GJ, Chen Y, Ciombor KK, Cohen SA, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber JM, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Gurski LA, Snedeker J, Jones F. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology, 2024.
- Chang GJ. The ASCRS Manual of Colon and Rectal Surgery: Rectal Cancer: Watch and Wait. Springer Nature, 2019.
- Chang G. Audio-Digest General Surgery Board Review: Multidisciplinary Treatment of Rectal Cancer. Audio-Digest Foundation, 2013.
- Chang GJ. Update on multidisciplinary therapy for locally advanced rectal cancer, 2012.
- Chang GJ. Molecular Profiling for Colon Cancer: PRO. American Society of Clinical Oncology Gastrointestinal Symposium Educational book, 2012.
- Chang, GJ. Update on multidisciplinary therapy for locally advanced rectal cancer, 2010.
- Chang GJ. Rectal Cancer Treatment Guidelines - Treatment Algorythm. MD Anderson Cancer Center, 2009.
- Chang GJ. Colon Cancer Treatment Guidelines - Treatment Algorythm. MD Anderson Cancer Center, 2009.
- Feig BW, Chang GJ. Sentinel Node Assessment in Colorectal Cancer: Potential Advantages and Obstacles." American Society of Clinical Oncology Educational Book, 2007.
- Chang GJ. Issues in the treatment of colorectal cancer: Not for surgeons only. Highlights of the American Society of Colon and Rectal Surgeons (ASCRS) 2005 Annual Meeting, 2005.
Editorials
- Guraieb-Trueba M, Chang GJ. Transanal vs Laparoscopic TME--all that Glitters is not Gold. Ann Surg 277(1):7-8, 2022. PMID: 35916131.
- Snyder RA, He J, Le-Rademacher J, Ou FS, Dodge AB, Zemla TJ, Paskett ED, Chang GJ, Innocenti F, Blanke C, Lenz HJ, Polite BN, Venook AP. Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931). Cancer 127(20):3801-3808, 2021. PMID: 34374082.
- Chang GJ. Primary Tumor Resection in Colorectal Cancer With Synchronous Unresectable Metastasis: Time to End the Debate?. J Clin Oncol 39(10):JCO2100057, 2021. PMID: 33591837.
- Snyder RA, Chang GJ. Insurance Status as a Surrogate for Social Determinants of Health in Cancer Clinical Trials. JAMA Netw Open 3(4):e203890, 2020. PMID: 32352526.
- Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Protectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267(3):521-526, 2018. PMID: 27997470.
- Chang GJ, Gonen M. Prognostic and Predictive Ability of Tumor Sidedness: Another Vexing Difference Between Localized and Advanced Colon Cancer. JAMA Oncol 3(10):1314-1315, 2017. PMID: 28594984.
- Sandhu L, Chang GJ. Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends?. JAMA Surg 152(4):e165659, 2017. PMID: 28196188.
- Chang GJ, Kopetz S. Coordination of Care in Colon Cancer. Cancer 121(18):3201-3202, 2015. PMID: 26043269.
- Chang GJ. Challenge of Primary Tumor Management in Patients with Stage IV Colorectal Cancer. J Clin Oncol 30(26):3165-6, 2012. PMID: 22869881.
Abstracts
- White M, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Berkova Z, Nguyen ST, Chang GJ, Wargo JA, Ajami NJ, Kopetz S, Y Nancy You. Tumoral microbial and pathway alterations associated with young-onset rectal cancer and its response to therapy, 2024. e-Pub 2024.
- Uppal A, Bhutiani N, YC Shen JP, Alfaro K, Kell RJ, Yousef MM, Yousef AM, Konishi T, Holliday E, Van K Morris II, Dasari A, Willis J, Newhook TE, Bednarski BK, Y Nancy You, Peacock O, Messick C, Das P, Chang GJ, Kopetz S. Association of pathologic nodal status with minimal residual disease after neoadjuvant treatment and resection of locally advanced rectal cancer, 2024. e-Pub 2024.
- Finlayson E, Gunn H, Barber A, Lowenstein LM, Dohan DP, Broering JM, Dockter T, Tan AD, Dueck AC, Bailey L, Chow SL, Wills R, Jatoi Am Lee EK, Delacoix SE, Gills J, Mulligan C, Hayseen T, Chang GJ. Geriatric pre-surgical optimization in the NCORP (Alliance), 2023. e-Pub 2023.
- Childers C, Manisundaram N, Hu CY, Tran Cao HS, Chang GJ. Association of the Robotic Approach With Delays in Surgery For Colon Cancer, 2023. e-Pub 2023.
- Childers C, Manisundaram, Hu CY, Chang GJ. Does Submitting A Modifier 22 Actually Work?, 2023. e-Pub 2023.
- Manisundaram N, Hu CY, Uppal A, Peacock O, Bednarski BK, Konishi T, White M, You YN, Messick C, Tillman MM, Skibber JM, Das P, Smith GL, Holliday E, Dasari A, Johnson B, Morris VK, Chang GJ. Is There an Increase in Elective Utilization of Non-Operative Management for Rectal Cancer?, 2023. e-Pub 2023.
- Chang GJ, Gunn H, Barger A, Lowenstein LM, Dohan DP, Broering JM, Dockter T, Tan AD, Dueck AC, Bailey L, Chow SL, Cleary RK, Mesleh M, Woodall C, Solfelt ML, Finlayson E. Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD), 2023. e-Pub 2023.
- Fox DA, Konishi T, Kaur H, You YN, Raghav KP, Ge PS, Messick CA, Johnson B, Morris VK, Thomas JV, Shah P, Bednarski BK, Kopetz S, Chang GJ, Ludford K, Hibie V, Overman MJ, Bhamidipati D. Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response, 2023. e-Pub 2023.
- Dasari A, Bent AH, Alfaro-Munoz K, Huey RW, Johnson B, Lee MS, Morelli MP, Morris VK, Overman MJ, Parseghian CM, Raghav KPS, Shen J, Willis J, Newhook TE, Uppal A, You YN, Konishi T Chang GJ, Kopetz S, Wolff RA. Association of positive ctDNA-based minimal residual disease assays during surveillance and undiagnosed concomitant radiographic recurrences in colorectal cancer (CRC): Results from the MD Anderson INTERCEPT program, 2023. e-Pub 2023.
- Corrigan KL, Holliday E, Guraieb-Trueba M, Peacock O, Skibber JM, Bednarski BK, Messick C, Tillman MM, Johnson B, Smith GL, Nguyen ST, Kundu S, Reinhardt A, Chang GJ Das P, You YN. A prospective evaluation of pelvic radiation vs. no radiation among patients with young-onset rectal cancer: Impact on patient-reported outcomes, 2023. e-Pub 2023.
- Manisundaram N, Snyder RA, Hu CY, DiBrito SR, Chang GJ. Racial Disparities in Cancer Mortality in Patients with Gastrointestinal Malignancies Following Medicaid Expansion, 2023. e-Pub 2023.
- Janak A, Peacock O, White M, Guraieb-Trueba M, Nguyen ST, Alshenaifi J, Kopetz S, Johnson B, Smith GL, Chang GJ, You YN. Internet-based assessment tools for predicting colorectal cancer risk: How do they communicate individualized risk to the young adult?, 2023. e-Pub 2023.
- Uppal A, White M, Chang GJ, Zeineddine FA, Zeineddine MA, Abdelrahman MG, Scally C, Fournier K, Newhook TE, You YN, Willis J, Kopetz S, Shen JP. Tumor Mutations Associated with Outcomes in Colorectal Peritoneal Metastases, 2023. e-Pub 2023.
- Janak A, Peacock O, White M, Guraieb-Trueba M, Nguyen ST, Alshenaifi J, Kopetz S, Johnson B, Smith GL, Chang GJ, You YN. Internet-based assessment tools for predicting colorectal cancer risk: How do they communicate individualized risk to the young adult?, 2023. e-Pub 2023.
- Bhutiani N, Hu CY, Palis BE, Cotler J, Shi Q, Goldberg RM, Washington MK, Nelson H, Steele S, Chang GJ. Lack of hierarchical survival prognosis in AJCC staging for colon cancer: Implications for future summary stage classification, 2023. e-Pub 2023.
- Agnes A, Peacock O, Manisundaram N, Konishi T, Bednarski B, Taggart M, Vikram R, Stanietzky N, You YN, Poster Presentaion CG. Evaluation of the learning-curve for robotic lateral pelvic lymph node dissection (LPLND) for the treatment of rectal cencer in a Western institution, 2022. e-Pub 2022.
- Martin AN, Tzeng CW, Arvide EM Skibber JM, GJ &, You YN, Bednarski BK, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Cumulative operative time and postoperative complication risk in synchronous resection of colorectal liver metastases and primary tumors, 2022. e-Pub 2022.
- Taku N, You YN, Ludmir EB, Smith GL, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Koong AC, Minsky BD, Holliday EB, Joay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Overman MJ, Kopez S, Raghav K, Das P. Clinical Outcomes Following Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer: A Single Institution Experience(suppl 15; abstr e15601), 2021. e-Pub 2021.
- Conti RM, McCue S, Dockter T, Rapkin BD, Dusetzina S, Bennett AV, Garcia G, Johnson ME, Martin SA, Chang GJ, Richardson PG, Behrens RJ, Weiss ES. Assessing Financial Difficulty In Patients With Multiple Myeloma: Preliminary Results of ALLIANCE A231602CD(suppl 15; abstr 8031), 2021. e-Pub 2021.
- You YN, Rodriguez-Bigas MA, Chang GJ, Bednarski BK, Skibber JM, Mork ME, Moskowitz JB, Nguyen ST, Thirumurthi S, Lynch PM, Kopetz S, Vilar Sanchez E. Are Current Family-history Based Colorectal Cancer Screening Guidelines Adequate For Early Detection And Potential Prevention Of Young-Onset Cases?(suppl 15; abstr 3549), 2021. e-Pub 2021.
- Swords DS, Tran Cao HS, Bednarski BK, Vauthey JN, Chang GJ, You YN. Treatment Disparities Partially Mediate Diminished Survival in Disadvantaged Black and White Patients with Stage IV Colorectal Cancer (CRC), 2021. e-Pub 2021.
- Zafar S, Hu C, Helmink B, Scally CP, Bednarski BK, Fournier KF, Chang GJ. Peritoneal Recurrence after Resection for Stage 1-3 Colorectal Cancer-A Popular Analysis, 2020. e-Pub 2020.
- Peacock O, Yun Y, Thirmurthi S, Nguyen S, Lim P, Rodriguez-bigas MA, Bednarski BK, Messick CA, Skibber JM, Chang GJ, Vilar E, You YN. Metachronous colorectal pathology among survivors of young-onset colorectal cancer: Implications for postresection colonoscopic surveillance, 2020. e-Pub 2020.
- Tilburt JC, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb R, Chang GJ, Morris MJ, Kovac E, Sloa JA, Basch EM, Storrick EM, Zahrieh D, Dueck AC, Paskett ED, Buckner JC, Montori V, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial, 2020. e-Pub 2020.
- Schrag D, Shi Q, Gollub MJ, Saltz LB, Chang GJ, Basch EM, Kolevska T, Gordon VL, Venook AP, O'Reilly EM, Meyerhardt JA, Mamon HJ. Selective versus standard use of neoadjuvant chemoradiation for locally advanced cancers prior to total mesorectal excision: surgical endpoints from the PROSPECT trial/N1048, 2020. e-Pub 2020.
- Zafar S, Hu C, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence after Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study, 2019. e-Pub 2019.
- Yang Y, Malakorn S, Zafar SN, Sandhu L, Chang GJ. Robotic Complete Mesocolic Excision for Right Colectomy in a High-BMI Patient: "SMV-first" Approach, 2019. e-Pub 2019.
- Malakorn S, Bednarski BK, You YN, Chang GJ. Tumor Sidedness, Recurrence and Survival Another Important Difference Between Localized Colon Cancer, 2019. e-Pub 2019.
- Healy M, Bednarski BK, Eng C, Das M, Rodriguez-Bigas MA, Skibber JM, Kaur H, Ernst R, Chang GJ, You YN. Higher Propensity for Nodal Metastases Among Young-Onset Rectal Cancers, 2019. e-Pub 2019.
- Sandhu L, Romero M, Weldon M, You YN, Bednarski BK, Chang GJ. Is Extended VTE Prophylaxis After Minimally Invasive Surgery for Colorectal Cancer Justified? Results of a Systematic Literature Review, 2018. e-Pub 2018.
- Chai CY, Chang GJ, Tran Cao H, Awad SS, Kimbrough BA, Artinyan A, Krishnan B, Massarweh NN. Management of Early Stage Squamous Cell Carcinoma of Anal Canal - Is Doing Less More, 2018. e-Pub 2018.
- Sammour T, Malakorm S, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Eng C, Das P, Skibber JM, You YN. Longitudinal Trajectory of Cancer Survivorship in Patients with Recurrent Rectal Cancer: Anatomy of Recurrence Impacts Quality of Life and Pain, 2017. e-Pub 2017.
- Adesoye T, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Van Loon K, Schrag D, McKellar DP, Winchester DP, Chang GJ. Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer, 2017. e-Pub 2017.
- Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick C, Taggart M, Chang GJ, You YN. Minimally Invasive Complete Mesocolic Excision and Central Vascualr Ligation: Defining the Radicality of Central Lymphadenectomy for Right Colon Cancer, 2017. e-Pub 2017.
- Sammour T, Malakorm S, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Eng C, Das P, Skibber JM, You YN. Longitudinal Trajectory of Cancer Survivorship in Patients with Recurrent Rectal Cancer: Anatomy of Recurrence Impacts Quality of Life and Pain, 2017. e-Pub 2017.
- Adesoye T, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Van Loon K, Schrag D, McKellar DP, Winchester DP, Chang GJ. Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer, 2017. e-Pub 2017.
- Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick C, Taggart M, Chang GJ, You YN. Minimally Invasive Complete Mesocolic Excision and Central Vascualr Ligation: Defining the Radicality of Central Lymphadenectomy for Right Colon Cancer, 2017. e-Pub 2017.
- Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Schrag D, McKellar D, Winchester D, Kozower B, Greenberg CC, Chang GJ. Intensity of Post-Treatment Surveillance Does Not Impact Survival in Colorectal Cancer, 2017. e-Pub 2017.
- Schumacher JR, Neuman HB, Zhang Y, Yu M, Vanness DJ, Si Y, Burnside ES, Ruddy KJ, Partridge AH, Schrag D, Edge SB, Jacobs EA, Havlena J, Francescatti AB, Winchester DP, McKellar DP, Spears PA, Chang GJ, Kozower BD, Greenberg CC. Asymptomatic distant recurrence detection and survival in early stage breast cancer: A nationally representative study, 2017. e-Pub 2017.
- Cuddy A, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Messick CA, Nguyen S, You YN. Primary Health Concerns Perceived by Long-Term Disease-Free Colorectal Cancer Survivors, 2016. e-Pub 2016.
- Lowenstein LM, Hempstead AP, Richards VF, Van Loon K, You YN, Volk RJ, Chang GJ. Patient Self-Advocacy in Decision Making Related to Post-Treatment Surveillance for Colorectal Cancer, 2016. e-Pub 2016.
- Patel SH, Chang GJ, Cuddy A, Mork ME, Bannon SA, Egger ME, Holder A, Bednarski BK, Skibber JM, Vilar-Sanchez E, Lynch PM, Rodriguez-Bigas MA, You YN. Decision for Non-Completion of Follow-Up Among Patients with Abnormal Screening Test for Heredity Colorectal Cancer Syndrome, 2016. e-Pub 2016.
- You YN, Chang GJ, Bailey CE, Tran Cao HS, Cuddy A, Bednarski B, Feig BW, Nguyen S, Rodriguez-Bigas MA, Skibber JM. Risks and Distribution of Secondary Cancers Among Long-Term Survivors of Colon and Rectal Cancer, 2016. e-Pub 2016.
- Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, McKellar D, Winchester DP, Chang GJ. Detection and Treatment of Colorectal Cancer (CRC) Recurrence During Routine Surveillance: A Nationwide Cohort Study 34(suppl; abstr e18137), 2016. e-Pub 2016.
- Lowenstein LM, Cuddy A, Hempstead AP, Richards V, You YN, Volk RJ, Chang GJ. Patient's Knowledge of Colorectal Cancer Surveillance and Recurrence: A Qualitative Study, 2016. e-Pub 2016.
- Van Loon K, Hu CY, Cuddy A, Bekaii-Saab T, Benson AB, Hall MJ, Lai L, Nurkin S, Skibber JM, Weiser MR, Schrag D, Chang GJ. How are Colorectal Cancer Patients Treated Following Cancer Recurrence During Follow-up?, 2016. e-Pub 2016.
- Bailey CE, Hu CY, Cuddy A, You YN, Chang GJ. Surveillance Imaging Following Colon Cancer Resection: Universal or Risk-Based?, 2015. e-Pub 2015.
- Morris VK, Rashid A, Rodriguez-Bigas MA, Das P, Wolff RA, Chang GJ, Crane CH, Phillips J, Ohinata A, Rogers J, Eng C. Association of human papillomavirus with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal 32(suppl 3; abstr 479), 2014. e-Pub 2014.
- You YN, Bednarski BK, Chang GJ, Nguyen S, Cuddy A, Feig BW, Skibber JM, Rodriguez-Bigas MA. Defining Phenotypes and Pedigrees in Young onset Colorectal Cancer, 2013. e-Pub 2013.
- Kopetz S, Jiang Z, Overman M, Rosenburg R, Salazar R, Tabernero J, Stork L, Li Y, Simon I, Chang GJ, Maru D. Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients J Clin Oncol 31(suppl; abstr 3612), 2013. e-Pub 2013.
- Chang GJ, Park IJ, Eng C, You YN, Kopetz S, Overman MJ, Rodriguez-Bigas MA, Skibber JM. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal Cancer J Clin Oncol 30(suppl; abstr 3556), 2012. e-Pub 2012.
- Eng C, Rogers J, Chang GJ, You YN, Das P, Rodriguez-Bigas MA, Ohinata A, Phillips J, Abbruzzese JL, Wolff RA. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal J Clini Oncol 30(suppl; abstr 4060), 2012. e-Pub 2012.
- Park IJ, You NY, Skibber JM, Rodriguez-Bigas MA, Feig BW, Nguyen ST, Chang GJ. Oral Presentation, Recurrence patterns after multidisciplinary therapy for rectal cancer in 725 patients, 2012. e-Pub 2012.
- Russell MC, Chiang YJ, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?, 2012. e-Pub 2012.
- Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-caucasian patients, 2012. e-Pub 2012.
- Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting herediatary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs, 2012. e-Pub 2012.
- Haynes A, Chiang YJ, Feig B, Xing Y, Chang GJ, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality, 2012. e-Pub 2012.
- Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggert MW, Skibber JM, Feig BW, You YN. Oral Presentation, Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?, 2012. e-Pub 2012.
- Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter? J Clin Oncol 30(suppl 4; abstr 575), 2012. e-Pub 2012.
- Haynes A, Chiang YJ, Feig B, Xing Y, Chang GJ, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality J Clin Oncol 30(suppl 4; abstr 541), 2012. e-Pub 2012.
- Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs J Clin Oncol 30(suppl 4; abstr 396), 2012. e-Pub 2012.
- Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients J Clin Oncol 30(suppl 4; abstr 417), 2012. e-Pub 2012.
- Mitchell MP, Abboud M, Crane C, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience J Clin Oncol 30(suppl 4; abstr 661), 2012. e-Pub 2012.
- Overman MJ, Fournier KF, Hu CY, Wolff RA, Eng C, Taggart MW, Royal RE, Mansfield PF, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histologic grade J Clin Oncol 30(suppl 4; abstr 402), 2012. e-Pub 2012.
- Boland GM, Chiang Y, Chagpar R, Xing Y, Hu CY, Fieg BW, Chang GJ, You N, Cormier JN. Association of NCCN guideline adherence with improved survival in hihg-risk stage II and III colon cancer J Clin Oncol 30(suppl 4; abstr 543), 2012. e-Pub 2012.
- Das P, Eng C, Rodriguez-Bigas, Chang GJ, Skibber JM, Maru D, Munsell MF, Clemons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial J Clin Oncol(suppl 4; abstr 544), 2012. e-Pub 2012.
- Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis J Clin Oncol 30(suppl 4; abstr 629), 2012. e-Pub 2012.
- Park IJ, Eng C, You YN, Kopetz S, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Chang GJ. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer J Clin Oncol 30(suppl 4: abstr 557), 2012. e-Pub 2012.
- Chang GJ, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer? J Clin Oncol 30(suppl 4; abstr 546), 2012. e-Pub 2012.
- Russell MC, Chiang Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind? J Clin Oncol 30(suppl 4; abstr 537), 2012. e-Pub 2012.
- Bailey C, Hu C, You N, Rodriguez-Bigas M, Kaur H, Ernst R, Skibber M, Chang GJ. Population-based trends in position emission tomography (PET) utilization after resection for colon cancer J Clin Oncol 30(suppl; abstr 3556), 2012. e-Pub 2012.
- Abbott DE, Aloia TA, Rodriguez-Bigas MA, Skibber JM, Feig BW, You NY, Curley SA, Vauthey JN, Chang GJ. Economic comparison of simultaneous and staged resection for synchronous metastatic colorectal cancer, 2011. e-Pub 2011.
- Park, IJ, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer J Clin Oncol 29(suppl; abstr 3553), 2011. e-Pub 2011.
- Chagpar R, Cormier JN, Feig BW, Chang GJ, You YN, Chiang M, Rodriguez-Bigas MA, Skibber JM, Xing Y. Adherence to NCCN treatment guidelines for rectal cancer: Analysis of national practice patterns J Clin Oncol 29(suppl; abstr 3554), 2011. e-Pub 2011.
- Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes is locally advanced rectal cancer: Establishing oncologic benchmarks J Clin Oncol 29(suppl; abstr 3545), 2011. e-Pub 2011.
- Chang GJ, You NY, Kaur H, Ernst RD. Can Pretreatment Rectal MRI Predict Response to Neoadjuvant Chemoradiation Therapy?, 2011. e-Pub 2011.
- Chagpar R, Cormier JN, Xing Y, Chiang Y, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW. Which stage II colon cancer patients are receiving recommendations for adjuvant chemotherapy? An analysis of current practices using the National Cancer Database, 2011. e-Pub 2011.
- Chagpar R, Xing Y, Hsu C, Cormier JN, Rashid A, Chiang Y, Feig BW, Chang GJ, You, YN. Comparison and validation of three staging systems for neuroendocrine tumors of the colon and rectum, 2011. e-Pub 2011.
- Jensen C, Ernst R, Chang GJ, You N, Hou P, Choi H, Rauch G, Kaur H. Preoperative MRI assessment of rectal cancer: Historical perspective to current trends, 2011. e-Pub 2011.
- Park IJ, You YN, Schlette E, Nguyen S, Rodriguez-Bigas MA, Skibber JM, Chang GJ. The “Reverse” Hybrid Robotic Mesorectal Excision for Rectal Cancer, 2011. e-Pub 2011.
- Hyngstrom JR, Hu C, Xing Y, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JM, Chang GJ. Clinicopathology and Outcomes with Mucinous and Signet Ring Colorectal Adenocarcinoma in the NCDB, 2011. e-Pub 2011.
- Hsu C, Rashid A, Xing Y, Chiang Y, Chang GJ, You N, Feig B, Cormier J. Histologic subtypes of neuroendocrine tumors of the appendix have varying malignant potential, 2011. e-Pub 2011.
- Chagpar R, Xing Y, You YN, Chiang Y, Feig BW, Chang GJ, Cormier JN. Predicting adherence to stage-specific treatment guidelines for adenocarcinoma of the colon, 2011. e-Pub 2011.
- You Y, Xing Y, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Ling YK, Cormier JN. Risk factors for colorectal cancer in patients younger than 50, 2011. e-Pub 2011.
- Hu C, Xing Y, Cormier JN, Chang GJ. The validity of cancer specific mortality within the surveillence, epidemiology, and end results registry, 2011. e-Pub 2011.
- Jiang Z, Mehta TR, You YN, Chang GJ, Eng C, Overman JM, Maru D, Hamilton SR, Kopetz S. Association of PTEN loss and local recurrence in stage II-III colon cancer J Clin Oncol 29(suppl; abstr 399), 2011. e-Pub 2011.
- Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas AM, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective, 2011. e-Pub 2011.
- You YN, Xing Y, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Cormier JN. Advanced-stage colon cancer prior to the screening age: Association with age, race, and insurance status J Clin Oncol 29(suppl; abstr 377), 2011. e-Pub 2011.
- Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas M. Structured reporting for MRI staging of rectal cancer, 2010. e-Pub 2010.
- You Y, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer, 2010. e-Pub 2010.
- Chang GJ, Maru D, Agarwal A, Schlette E, Wolff R, Rodriguez-Bigas M, You N, Feig B, Kopetz S, Skibber J, Eng C. Histophathologic responses in primary tumors of patients with metastatic colorectal carcinoma after neoadjuvant systemic chemotherapy alone, 2010. e-Pub 2010.
- You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer, 2010. e-Pub 2010.
- McAuliffe PF, Gershenwald JE, Lee JE, Badgwell BD, Ballo MT, Cormier JN, Mansfield PF, Chang GJ, Zagars GK, Camp ER. Role of sentinel lymph node biopsy in anorectal melanoma, 2010. e-Pub 2010.
- Bowles TL, Hu, C, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Cancers of the Colon and Rectum, 2010. e-Pub 2010.
- Eng C, Sethi S, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Shen J, Zhu J, Ohinata A, Hamilton SR, Li D. Proteomic analysis of potential tumor markers in AJCC stage II and III colon cancer, 2009. e-Pub 2009.
- Eng C, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal, 2009. e-Pub 2009.
- Overman MJ, Hu CY, Wolff RA, Chang GJ. Impact of lymph node evaluation on survival for small bowel adenocaricnoma (SBA): Analysis of the Surveillance, Epidemiology and End Results (SEER) database, 2009. e-Pub 2009.
- Hu C, Xing Y, Cormier JN, Chang GJ. The validity of cause of death coding within the surveillance, epidemiology, and end results (SEER) registry, 2009. e-Pub 2009.
- Fukami N, Skibber JM, Chang GJ. Salvage endoscopic antegrade dilation on tight or complete coloanal anastomotic stricture via ileostomy, 2009. e-Pub 2009.
- Xing Y, Chang GJ, Hu C, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates provide better prognostic information for melanoma survivors: result from the SEER dataset 1988-2000, 2009. e-Pub 2009.
- Bedrosian I, Hu CY, Chang GJ. Contralateral prophylactic mastectomy and survival, 2008. e-Pub 2008.
- Chang GJ, Hu C, Rodriguez-Bigas MA, Skibber JM. Improving colon cancer prognosis using index of metastasis: A SEER analysis, 2008. e-Pub 2008.
- Chang GJ, Taylor SH, Rodriguez-Bigas MA, Eng C, Skibber JM. The twelve lymph node standard in colon cancer: Can it be achieved?, 2008. e-Pub 2008.
- Bowles TL, Xing Y, Mungovan KS, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Conditional survival estimates improve over 5 years for patients with node-positive melanoma, 2008. e-Pub 2008.
- Chang GJ, Taylor SH, Rodriguez-Bigas MA, Eng C, Skibber JM. The twelve lymph node standard in colon cancer: Can it be achieved?, 2008. e-Pub 2008.
- Chang GJ, Hu C, Eng C, Skibber JM, Rodriguez-Bigas MA. An epidemiologic study of conditional survival in colon cancer, 2008. e-Pub 2008.
- Chang GJ, Hu C, Rodriguez-Bigas MA, Eng C, Skibber JM. Improving colon cancer prognosis using index of metastasis: A SEER analysis, 2008. e-Pub 2008.
- Kesmodel SB, Ellis LM, Lin E, Chang GJ, Ebdalla EK, Kopetz ES, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not increase postoperative complications in patients undergoing hepatic surgery for colorectal cancer liver metastases, 2007. e-Pub 2007.
- Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Predicting outcomes after surgery for locally recurrent rectal cancer, 2007. e-Pub 2007.
- Chang GJ, Rodriguez-Bigas MA, Skibber JM. An epidemiologic study of N-stage after preoperative radiotherapy for rectal cancer, 2007. e-Pub 2007.
- Badgwell B, Feig BW, Ross M, Mansfield PM, Chang GJ. Pneumoperitoneum in the cancer patient, 2007. e-Pub 2007.
- Gray KD, Feng L, Skibber JM, Chang GJ, Rodriguez-Bigas MA. Ethnic disparities in colorectal cancer outcomes persist despite treatment at a comprehensive cancer center, 2007. e-Pub 2007.
- Al-Refaie WB, Pisters PW, Chang GJ. Gastric adenocarcinoma in young patients: A population-based appraisal, 2007. e-Pub 2007.
- Das P, Bhatia S, Eng C, Ajani, JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Krishnan S, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer, 2007. e-Pub 2007.
- Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Krishnan S, Janjan N, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer, 2007. e-Pub 2007.
- Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. An epidemiologic study of N-stage and prognosis after preoperative radiotherapy for rectal cancer, 2007. e-Pub 2007.
- Lim SJ, Feig BW, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Cleary K, Chang GJ. Evaluation of sentinel lymph node for staging accuracy in colon cancer, 2007. e-Pub 2007.
- Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey N, Rodriguez-Bigas MA, Curley SA, Feig BW. Complication rates following hepatic surgery in patients receiving neoadjuvant bevacizumab (BC) for colorectal cancer (CRC) liver metastases, 2007. e-Pub 2007.
- Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Surgical salvage with bone resection for locally recurrent rectal cancer, 2007. e-Pub 2007.
- Al-Refaie WB, Pisters PW, Chang GJ. Proximal versus total gastrectomy for proximal gastric cancer, 2007. e-Pub 2007.
- Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Composite sacral resection for recurrent rectal cancer, 2007. e-Pub 2007.
- Zager JS, Gannon CJ, Chang GJ, Feig BW, Skibber J, Rodriguez-Bigas MA. Pelvic exenteration affords safe and durable treatment for locally advanced rectal adenocarcinoma (LARC), 2006. e-Pub 2006.
- Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas MA. Extending the limits for sphincter preservation for rectal cancer with margins less than or equal to 1cm, 2006. e-Pub 2006.
- Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Ra W, Eng C, Janjan NA, Krishnan S, Crane CH. Predictors of tumor responlse and downstaging in patients treated with preoperative chemoradiation for rectal cancer 66 (Suppl):S167-68, 2006. e-Pub 2006.
- Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas MA. Are we under-treating rectal cancer in elderly patients? A population based appraisal, 2006. e-Pub 2006.
- Choi E, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Predicting outcome after aggresive surgical resection of locally recurrent rectal cancer, 2006. e-Pub 2006.
- Chang GJ, Kattepogu KM, Wey J, Gannon C, Crane CH, Janjan N, Feig BW, Skibber JM, Rodriguez-Bigas MA. sphincter preservation in distal rectal cancer beyond the 2 cm rule, 2006. e-Pub 2006.
- Das P, Bhatia Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Ellis LM, Lin EH, Janjan N, Crane C. Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: a matched case-control study, 2005. e-Pub 2005.
- Chang GJ, Liu T, Feng S, Bedolli M, O’Rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts, 2002. e-Pub 2002.
- Chang GJ, Adey D, Tomlanovich S, Amend W, Vincenti F. Early Histology, Acute Rejection, and Outcome in Renal Transplant Patients with Severe Delayed Graft Function Treated with a Calcineurin Inhibitor-Free Regimen 12:882A, 2001. e-Pub 2001.
- Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high grade anal squamous intraepithelial lesions—a prospective study, 2001. e-Pub 2001.
- Chang GJ, Freise CE, Hirose R, Ascher NL, Roberts JP, Vincenti F, Stock PG. A new immunosuppressive era—transplantation without steroids, 2000. e-Pub 2000.
- Chang GJ, Vincenti F, Robert JP, Stock PG, Hirose R. Sirolimus provides effective immunosupression in kidney transplant recipients with delayed or impaired graft function, 2000. e-Pub 2000.
- Chang GJ, Mahanty HD, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of Sirolimus in Liver Transplantation—Use in patients for whom calcineurin inhibitors are contraindicated 32/(4:2/2):344A, 2000. e-Pub 2000.
- Chang GJ, Ascher NL, Freise CE, Jaskula J, Mathias R, Portale A, Potter DE, Stock PG. Daclizumab provides superior immunosuppresion for pediatric renal transplants 67(9):S585, 1999. e-Pub 1999.
- Chang GJ, O’Rourke R, Lee I, Stock PG, Vincenti F. One or Two Doses of Dacluzimab Provide Effective Immunosuppression for Renal Transplant Patients with High Immunologic Risk or with Delayed Graft Function 67(7):S149, 1999. e-Pub 1999.
- Berber E, Engle KL, Chang GJ, Macho J, Pear JM. Selective use of tube cholecystostomy with interval laparoscopic cholecystectomy in acute cholecystitis, 1998. e-Pub 1998.
- Chang GJ, Honda HM, Ignarro LJ, Demer LL. Nitrix oxide oxides low density lipoprotein in a pH-dependent manner, 1993. e-Pub 1993.
- Moskowitz JB, Mork ME, Maghanoy E, Nguyen ST, Harrison DM, Lovero KR, Das P, Chang GJ, Thirumurthi S, Ricciardiello L, Sanchez EV, You Y. Empowering young-onset colorectal cancer patients with an accessible, self-navigable online platform for universal germline testing. 2025 ASCO Annual Meeting.
- Basch E, Dueck AC, Mitchel SA, Mamon HJ, Rogak LJ, Ginos BF, Weiser MR, Saltz LB, Chang GJ, Minasian LM, Denicoff AM, Thanarajasingam G, Rubinson DA, Gordon VL, Goerge TJ, Farma JM, O'Reilly EM, Meyerhardt JA, Shi Q, Scrag D. PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048). 2023 ASCO Annual Meeting.
- Bhutiani N, Johnson B, Kopetz S, White M, Willis J, Uppal A, Chang GJ. Immune Checkpoint Blockade Combined with Targeted Therapies Provide Increased Disease Control in Mismatch Repair-Proficient Colorectal Cancer with Peritoneal Metastases. ASCO Gastrointestinal Cancers Symposium.
- Chang GJ, Childers CP, Hu CY. Impact of 2021 & 2023 Evaluation & Management (E&M) Code Updates on Surgical Oncologists. SSO 2024 Annual Meeting.
- Konishi T, Uppal A, White M, Messick C, You YN, Skibber J, Bednarski BK, Chang GJ. Robotic Nerve-Preserving Lateral Lymph Node Dissection with Major Vessel Ligation - When and How We Do It?. 2024 American Society of Colon and Rectal Surgeons.
- Ochiai K, Stanietzky N, Surabhi V, Ikeda A, Uppal A, White MG, Peacock O, Messick CA, Bednarski BK, You YN, Skibber JM, Kaur H, Chang GJ, Konishi T. Splenic enlargement after neoadjuvant chemotherapy predicts postoperative complications after curative proctectomy for rectal cancer. 2024 American Society of Colon and Rectal Surgeons.
- Diggs LP, Galbraith NJ, Ramamurthy J, Bhutiani N, Hu ZI, Dasari A, Overman MJ, Kopetz S, Chang GJ, Bednarski BK, Trueba MG, Behman RS, Yin F, Ajami NJ, Wargo JA, Bullman S, Johnston CD, You Y, White M. A phase II trial utilizing metronidazole to optimize the microbiome of rectal adenocarcinoma undergoing neoadjuvant therapy. 2025 ASCO Annual Meeting.
- Ochiai K, Bhutiani N, Uppal A, You Y, Bednarski BK, White M, Holliday E, Das P, Chang GJ, Konishi T. Long-course chemoradiation vs short-course radiation in total neoadjuvant therapy for rectal cancer: propensity score case-matched analysis. 2025 ASCO Gastrointestinal Cancers Symposium.
- Miyakawa T, Lie JJ, Hu C, Ochiai K, Behman RS, Guraieb-Trueba M, Bednarski BK, Konishi T, Messick C, You Y, Holliday E, Noticewala SS, Das P, Kaur H, Rauch GM, Huey RW, Dasari A, Chang GJ. Survival outcomes in rectal cancer with ypTNM vs pTNM staging after neoadjuvant therapy. 2025 ASCO Annual Meeting.
- Shi Q, Chang GJ, Pederson LD, Asare EA, Jin Z, Cohen R, Meyerhardt JA, Andre T, Tie J, Dixon JG, Palis BE, Ballman KV, Yothers G, Ma Z, Alberts SR, Shi C, Washington MK, Taieb J, Steele S, Goldberg RM. Proposed changes to the pathologic staging for colon cancer (CC): AJCC Colon Cancer Expert Panel (AJCCCCEP). 2025 ASCO Annual Meeting.
Book Chapters
- Bednarski, BK, Chang, GJ. Exenterative Resections Involving Vascular and Pelvic Sidewall Structures, 110-119, 2021.
- Malakorn, S, Sammour, T, Chang, GJ. Robotic pelvic exenteration, 259-273, 2019.
- Chang GJ, Ninan T. Colorectal Cancer Survivorship Care. In: Handbook of Cancer Survivorship Care. Springer, 2018.
- Loehrer AP, Chang GJ. Implications of the Affordable Care Act on Surgery and Cancer Care. In: Surg Oncol Clin N Am. 4, 603-614, 2018.
- Karanjawala, BE, Chang, GJ. Management of anal cancer, 555-566, 2015.
- Karanjawala BE, Chang GJ. Management of Anal Cancer. In: Pelvic Cancer Surgery: Modern Breakthroughs and Future Advances. Springer, 555-66, 2015.
- Bailey CE, Chang GJ. Clinical Trials: Handling the Data. In: Success in Academic Surgery: Clinical Trials. 2014. Springer, 2014.
- Park IJ, Chang GJ. Salvage Surgery for Recurrent/Persistent Anal Cancer". In: Anal Cancer, A Multidisciplinary Approach. Demos Medical, 2013.
- Pineda, CE, Chang, GJ, Welton, ML. Surgery in the Immunocompromised Patient, 2262-2272, 2012.
- Chang GJ. Surgical Mentoring: Building Tomorrow's Leaders. In: Diseases of the Colon & Rectum. Springer, 2012.
- Chang GJ, Shelton A, Welton ML. Large Instestine. In: Current Surgical Therapy. Appleton, 2009.
- Welton, ML, Shelton, A, Chang, GJ, Varma, MG. Colon, rectum, and anus, 1011-1110, 2008.
- Welton ML, Shelton A, Chang GJ, Varma M. Colon, Rectum, and Anus. In: Surgery: Basic Science and Clinical Evidence. Springer-Verlag, 2008.
- Chang GJ. Open and Laparoscopic Surgery for Colon Cancer. In: Advanced Therapy in Surgical Oncology. Decker Press, 2007.
- Shelton A, Chang GJ, Welton ML. Small Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2006.
- Chang GJ, Feig BW. Cancer of the Colon, Rectum, and Anus. In: The M.D. Anderson Surgical Oncology Handbook. W.B. Saunders. Lippincott Williams & Wilkins, 2006.
- Chang GJ, Shelton A, Welton ML. Large Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2006.
- Chang GJ, Welton ML. Surgery in the Immunocompromised Patient. In: Shackelford’s Surgery of the Alimentary Tract. W.B. Saunders, 2005.
- Welton ML, Chang GJ. Anorectum. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2005.
- Chang GJ, Shelton A, Schrock TR, Welton ML. Large Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2002.
- Chang GJ, Welton ML. Surgery in the Immunocompromised Patient. In: Shackelford’s Surgery of the Alimentary Tract. W.B. Saunders, 2002.
- Chang GJ, Welton ML. Other Abdominal Emergencies: Appendicitis, Diverticulitis, and Ischemic Bowel. In: Hospital Medicine. Lippincott Williams & Wilkins, 683-694, 2000.
- Massarweh N, Chang GJ. Comparative Effectiveness Research. In: Success in Academic Surgery: Health Services Research.
- deRosa N, Chang GJ. Locally advanced and recurrent rectal cancer. In: Scientific American Surgery.
Books (edited and written)
- Hunt, KK, Katz, MH, Veeramachaneni, N, Grubbs, EG, Wang, TS, Kanf, JM, Fields, RC, Maithee, SK, Chang, GJ, Halverson, AL, Reddy, RM, Martin, LW, Francfsatti, AB. Operative standards for cancer surgery, 2018.
- Hunt, KK, Katz, MH, Veeramachaneni, N, Grubbs, EG, Wang, TS, Kanf, JM, Fields, RC, Maithee, SK, Chang, GJ, Halverson, AL, Reddy, RM, Martin, LW, Francfsatti, AB. Operative standards for cancer surgery, 2018.
- Chang, GJ. Rectal cancer, 2018.
- Chang GJ. Rectal Cancer: Modern Approaches to Treatment. Springer Nature, 2018.
- Chang GJ. Operative Standards for Cancer Surgery, 2018.
- Chang GJ. Operative Standards for Cancer Surgery. Lippincott Williams & Wilkins, 2015.
Letters to the Editor
- Massarweh NN, Hu CY, Rodriguez-Bigas MA, Chang GJ. Reply to N.H. Turner et al and L. Dziki et al. J Clin Oncol 33: 1412, 2015.
- Maru DM, Agarwal AA, Hu CY, Chang GJ. Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?. Cancer 120: 1282, 2014.
Patient Reviews
CV information above last modified March 27, 2026
